Hotline: +86-18022463983    020-85206863

Global Plasma Therapy Market Research Report 2026

Published Date: 2026-03-02   |   Pages: 111   |   Tables: 113   |  Medical Care

The global Plasma Therapy market was valued at US$ 357 million in 2025 and is anticipated to reach US$ 690 million by 2032, at a CAGR of 10.0% from 2026 to 2032.
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
North America is the largest consumption place, with a consumption market share nearly 53% . Europe is the second largest consumption place with the consumption market share of 26%. Terumo, Arthrex, Zimmer Biomet, DePuy Synthes and EmCyte are the leaders of the industry, top 3 companies occupied about 55% market share.
This report delivers a comprehensive overview of the global Plasma Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Plasma Therapy. The Plasma Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Plasma Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Plasma Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Segment by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Plasma Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Pure PRP
1.2.3 Leucocyte-rich PRP
1.2.4 Leukocyte-rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Plasma Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Orthopedic
1.3.3 Darmatology
1.3.4 Cardiac Muscle Injury
1.3.5 Dental
1.3.6 Nerve Injury
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plasma Therapy Market Perspective (2021–2032)
2.2 Global Plasma Therapy Growth Trends by Region
2.2.1 Global Plasma Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Plasma Therapy Historic Market Size by Region (2021–2026)
2.2.3 Plasma Therapy Forecasted Market Size by Region (2027–2032)
2.3 Plasma Therapy Market Dynamics
2.3.1 Plasma Therapy Industry Trends
2.3.2 Plasma Therapy Market Drivers
2.3.3 Plasma Therapy Market Challenges
2.3.4 Plasma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Therapy Players by Revenue
3.1.1 Global Top Plasma Therapy Players by Revenue (2021–2026)
3.1.2 Global Plasma Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Plasma Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Plasma Therapy Revenue
3.4 Global Plasma Therapy Market Concentration Ratio
3.4.1 Global Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Therapy Revenue in 2025
3.5 Global Key Players of Plasma Therapy Head Offices and Areas Served
3.6 Global Key Players of Plasma Therapy, Products and Applications
3.7 Global Key Players of Plasma Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Plasma Therapy Breakdown Data by Type
4.1 Global Plasma Therapy Historic Market Size by Type (2021–2026)
4.2 Global Plasma Therapy Forecasted Market Size by Type (2027–2032)
5 Plasma Therapy Breakdown Data by Application
5.1 Global Plasma Therapy Historic Market Size by Application (2021–2026)
5.2 Global Plasma Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Plasma Therapy Market Size (2021–2032)
6.2 North America Plasma Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Plasma Therapy Market Size by Country (2021–2026)
6.4 North America Plasma Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plasma Therapy Market Size (2021–2032)
7.2 Europe Plasma Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Plasma Therapy Market Size by Country (2021–2026)
7.4 Europe Plasma Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Plasma Therapy Market Size (2021–2032)
8.2 Asia-Pacific Plasma Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Plasma Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Plasma Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Plasma Therapy Market Size (2021–2032)
9.2 Latin America Plasma Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Plasma Therapy Market Size by Country (2021–2026)
9.4 Latin America Plasma Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Therapy Market Size (2021–2032)
10.2 Middle East & Africa Plasma Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Plasma Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Plasma Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Terumo
11.1.1 Terumo Company Details
11.1.2 Terumo Business Overview
11.1.3 Terumo Plasma Therapy Introduction
11.1.4 Terumo Revenue in Plasma Therapy Business (2021–2026)
11.1.5 Terumo Recent Development
11.2 Arthrex
11.2.1 Arthrex Company Details
11.2.2 Arthrex Business Overview
11.2.3 Arthrex Plasma Therapy Introduction
11.2.4 Arthrex Revenue in Plasma Therapy Business (2021–2026)
11.2.5 Arthrex Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Plasma Therapy Introduction
11.3.4 Zimmer Biomet Revenue in Plasma Therapy Business (2021–2026)
11.3.5 Zimmer Biomet Recent Development
11.4 DePuy Synthes
11.4.1 DePuy Synthes Company Details
11.4.2 DePuy Synthes Business Overview
11.4.3 DePuy Synthes Plasma Therapy Introduction
11.4.4 DePuy Synthes Revenue in Plasma Therapy Business (2021–2026)
11.4.5 DePuy Synthes Recent Development
11.5 EmCyte
11.5.1 EmCyte Company Details
11.5.2 EmCyte Business Overview
11.5.3 EmCyte Plasma Therapy Introduction
11.5.4 EmCyte Revenue in Plasma Therapy Business (2021–2026)
11.5.5 EmCyte Recent Development
11.6 Regen Lab
11.6.1 Regen Lab Company Details
11.6.2 Regen Lab Business Overview
11.6.3 Regen Lab Plasma Therapy Introduction
11.6.4 Regen Lab Revenue in Plasma Therapy Business (2021–2026)
11.6.5 Regen Lab Recent Development
11.7 ISTO Biologics
11.7.1 ISTO Biologics Company Details
11.7.2 ISTO Biologics Business Overview
11.7.3 ISTO Biologics Plasma Therapy Introduction
11.7.4 ISTO Biologics Revenue in Plasma Therapy Business (2021–2026)
11.7.5 ISTO Biologics Recent Development
11.8 Cesca Therapeutics
11.8.1 Cesca Therapeutics Company Details
11.8.2 Cesca Therapeutics Business Overview
11.8.3 Cesca Therapeutics Plasma Therapy Introduction
11.8.4 Cesca Therapeutics Revenue in Plasma Therapy Business (2021–2026)
11.8.5 Cesca Therapeutics Recent Development
11.9 Weigao
11.9.1 Weigao Company Details
11.9.2 Weigao Business Overview
11.9.3 Weigao Plasma Therapy Introduction
11.9.4 Weigao Revenue in Plasma Therapy Business (2021–2026)
11.9.5 Weigao Recent Development
11.10 REV-MED
11.10.1 REV-MED Company Details
11.10.2 REV-MED Business Overview
11.10.3 REV-MED Plasma Therapy Introduction
11.10.4 REV-MED Revenue in Plasma Therapy Business (2021–2026)
11.10.5 REV-MED Recent Development
11.11 Nuo Therapeutics
11.11.1 Nuo Therapeutics Company Details
11.11.2 Nuo Therapeutics Business Overview
11.11.3 Nuo Therapeutics Plasma Therapy Introduction
11.11.4 Nuo Therapeutics Revenue in Plasma Therapy Business (2021–2026)
11.11.5 Nuo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Plasma Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Pure PRP
Table 3. Key Players of Leucocyte-rich PRP
Table 4. Key Players of Leukocyte-rich Fibrin (L-PRF)
Table 5. Global Plasma Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Plasma Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Plasma Therapy Market Size by Region (US$ Million), 2021–2026
Table 8. Global Plasma Therapy Market Share by Region (2021–2026)
Table 9. Global Plasma Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Plasma Therapy Market Share by Region (2027–2032)
Table 11. Plasma Therapy Market Trends
Table 12. Plasma Therapy Market Drivers
Table 13. Plasma Therapy Market Challenges
Table 14. Plasma Therapy Market Restraints
Table 15. Global Plasma Therapy Revenue by Players (US$ Million), 2021–2026
Table 16. Global Plasma Therapy Market Share by Players (2021–2026)
Table 17. Global Top Plasma Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Plasma Therapy Revenue, 2025
Table 18. Ranking of Global Top Plasma Therapy Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Plasma Therapy Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Plasma Therapy, Headquarters and Area Served
Table 21. Global Key Players of Plasma Therapy, Products and Applications
Table 22. Global Key Players of Plasma Therapy, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Plasma Therapy Market Size by Type (US$ Million), 2021–2026
Table 25. Global Plasma Therapy Revenue Market Share by Type (2021–2026)
Table 26. Global Plasma Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Plasma Therapy Revenue Market Share by Type (2027–2032)
Table 28. Global Plasma Therapy Market Size by Application (US$ Million), 2021–2026
Table 29. Global Plasma Therapy Revenue Market Share by Application (2021–2026)
Table 30. Global Plasma Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Plasma Therapy Revenue Market Share by Application (2027–2032)
Table 32. North America Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Plasma Therapy Market Size by Country (US$ Million), 2021–2026
Table 34. North America Plasma Therapy Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Plasma Therapy Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Plasma Therapy Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Plasma Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Plasma Therapy Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Plasma Therapy Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Plasma Therapy Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Plasma Therapy Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Plasma Therapy Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Plasma Therapy Market Size by Country (US$ Million), 2027–2032
Table 47. Terumo Company Details
Table 48. Terumo Business Overview
Table 49. Terumo Plasma Therapy Product
Table 50. Terumo Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 51. Terumo Recent Development
Table 52. Arthrex Company Details
Table 53. Arthrex Business Overview
Table 54. Arthrex Plasma Therapy Product
Table 55. Arthrex Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 56. Arthrex Recent Development
Table 57. Zimmer Biomet Company Details
Table 58. Zimmer Biomet Business Overview
Table 59. Zimmer Biomet Plasma Therapy Product
Table 60. Zimmer Biomet Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 61. Zimmer Biomet Recent Development
Table 62. DePuy Synthes Company Details
Table 63. DePuy Synthes Business Overview
Table 64. DePuy Synthes Plasma Therapy Product
Table 65. DePuy Synthes Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 66. DePuy Synthes Recent Development
Table 67. EmCyte Company Details
Table 68. EmCyte Business Overview
Table 69. EmCyte Plasma Therapy Product
Table 70. EmCyte Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 71. EmCyte Recent Development
Table 72. Regen Lab Company Details
Table 73. Regen Lab Business Overview
Table 74. Regen Lab Plasma Therapy Product
Table 75. Regen Lab Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 76. Regen Lab Recent Development
Table 77. ISTO Biologics Company Details
Table 78. ISTO Biologics Business Overview
Table 79. ISTO Biologics Plasma Therapy Product
Table 80. ISTO Biologics Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 81. ISTO Biologics Recent Development
Table 82. Cesca Therapeutics Company Details
Table 83. Cesca Therapeutics Business Overview
Table 84. Cesca Therapeutics Plasma Therapy Product
Table 85. Cesca Therapeutics Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 86. Cesca Therapeutics Recent Development
Table 87. Weigao Company Details
Table 88. Weigao Business Overview
Table 89. Weigao Plasma Therapy Product
Table 90. Weigao Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 91. Weigao Recent Development
Table 92. REV-MED Company Details
Table 93. REV-MED Business Overview
Table 94. REV-MED Plasma Therapy Product
Table 95. REV-MED Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 96. REV-MED Recent Development
Table 97. Nuo Therapeutics Company Details
Table 98. Nuo Therapeutics Business Overview
Table 99. Nuo Therapeutics Plasma Therapy Product
Table 100. Nuo Therapeutics Revenue in Plasma Therapy Business (US$ Million), 2021–2026
Table 101. Nuo Therapeutics Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report


List of Figures
Figure 1. Plasma Therapy Picture
Figure 2. Global Plasma Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Plasma Therapy Market Share by Type: 2025 vs 2032
Figure 4. Pure PRP Features
Figure 5. Leucocyte-rich PRP Features
Figure 6. Leukocyte-rich Fibrin (L-PRF) Features
Figure 7. Global Plasma Therapy Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Plasma Therapy Market Share by Application: 2025 vs 2032
Figure 9. Orthopedic Case Studies
Figure 10. Darmatology Case Studies
Figure 11. Cardiac Muscle Injury Case Studies
Figure 12. Dental Case Studies
Figure 13. Nerve Injury Case Studies
Figure 14. Plasma Therapy Report Years Considered
Figure 15. Global Plasma Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Plasma Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Plasma Therapy Market Share by Region: 2025 vs 2032
Figure 18. Global Plasma Therapy Market Share by Players in 2025
Figure 19. Global Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Plasma Therapy Revenue in 2025
Figure 21. North America Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Plasma Therapy Market Share by Country (2021–2032)
Figure 23. United States Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Plasma Therapy Market Share by Country (2021–2032)
Figure 27. Germany Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Plasma Therapy Market Share by Region (2021–2032)
Figure 35. China Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Plasma Therapy Market Share by Country (2021–2032)
Figure 43. Mexico Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Plasma Therapy Market Share by Country (2021–2032)
Figure 47. Israel Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Plasma Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Terumo Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 51. Arthrex Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 52. Zimmer Biomet Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 53. DePuy Synthes Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 54. EmCyte Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 55. Regen Lab Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 56. ISTO Biologics Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 57. Cesca Therapeutics Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 58. Weigao Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 59. REV-MED Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 60. Nuo Therapeutics Revenue Growth Rate in Plasma Therapy Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Our Clients